Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infants
- 29 February 2004
- journal article
- clinical trial
- Published by Elsevier in The Journal of Pediatrics
- Vol. 144 (2), 184-190
- https://doi.org/10.1016/j.jpeds.2003.10.054
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Intussusception among Infants Given an Oral Rotavirus VaccineNew England Journal of Medicine, 2001
- Current status and future priorities for rotavirus vaccine development, evaluation and implementation in developing countriesVaccine, 1999
- Prevention of Rotavirus Disease: Guidelines for Use of Rotavirus VaccinePediatrics, 1998
- Cost-effectiveness Analysis of a Rotavirus Immunization Program for the United StatesJAMA, 1998
- The Epidemiology Of Rotavirus Diarrhea In The United States: Surveillance And Estimates Of Disease BurdenThe Journal of Infectious Diseases, 1996
- Development of an improved method for measuring neutralizing antibody to rotavirusJournal of Virological Methods, 1991
- Serotype 1 reassortant of bovine rotavirus WC3, strain WI79-9, induces a polytypic antibody response in infantsVaccine, 1990
- Immune Protection of Infants against Rotavirus Gastroenteritis by a Serotype 1 Reassortant of Bovine Rotavirus WC3The Journal of Infectious Diseases, 1990
- Protection of Adults Rechallenged with a Human RotavirusThe Journal of Infectious Diseases, 1990
- Protective Effect of WC3 Vaccine Against Rotavirus Diarrhea in Infants During a Predominantly Serotype 1 Rotavirus SeasonThe Journal of Infectious Diseases, 1988